Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
1-Year Return
24.55%
This Quarter Return
+13.19%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$20.6B
AUM Growth
+$2.71B
(+15%)
Cap. Flow
+$680M
Cap. Flow
% of AUM
3.3%
Top 10 Holdings %
Top 10 Hldgs %
26.44%
Holding
1,633
New
69
Increased
616
Reduced
374
Closed
77
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$156M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Adobe
ADBE
|
+$73.7M |
| 4 |
Apple
AAPL
|
+$70.5M |
| 5 |
Core & Main
CNM
|
+$70.3M |
Top Sells
| 1 |
Linde
LIN
|
+$64.6M |
| 2 |
Reinsurance Group of America
RGA
|
+$53.5M |
| 3 |
Medtronic
MDT
|
+$38.2M |
| 4 |
Molina Healthcare
MOH
|
+$35.6M |
| 5 |
Alibaba
BABA
|
+$31.5M |
Sector Composition
| 1 | Technology | 32.7% |
| 2 | Healthcare | 19.57% |
| 3 | Financials | 10.49% |
| 4 | Industrials | 10.21% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Carter's
CRI
$1.04B
| $452K | ﹤0.01% |
6,030
| – | – |
|
1202
ePlus
PLUS
$1.93B
| $451K | ﹤0.01% |
5,644
| – | – |
|
|
EQC
1203
DELISTED
Equity Commonwealth
EQC
| $451K | ﹤0.01% |
23,503
| – | – |
|
1204
Papa John's
PZZA
$1.63B
| $446K | ﹤0.01% |
5,851
| – | – |
|
1205
Crinetics Pharmaceuticals
CRNX
$3.3B
| $445K | ﹤0.01% |
+12,500
| New | +$445K |
|
1206
RXO
RXO
$2.74B
| $442K | ﹤0.01% |
19,000
| – | – |
|
1207
Tennant Co
TNC
$1.5B
| $442K | ﹤0.01% |
4,765
| – | – |
|
1208
Cimpress
CMPR
$1.44B
| $440K | ﹤0.01% |
5,496
-1,500
| -21% | -$120K |
|
1209
CVB Financial
CVBF
$2.8B
| $440K | ﹤0.01% |
21,811
| – | – |
|
1210
IonQ
IONQ
$13.1B
| $439K | ﹤0.01% |
35,400
+13,200
| +59% | +$164K |
|
1211
PJT Partners
PJT
$4.37B
| $438K | ﹤0.01% |
4,300
+1,700
| +65% | +$173K |
|
1212
Tandem Diabetes Care
TNDM
$836M
| $438K | ﹤0.01% |
14,800
+4,100
| +38% | +$121K |
|
1213
Pegasystems
PEGA
$9.66B
| $437K | ﹤0.01% |
17,888
+5,600
| +46% | +$137K |
|
|
JBGS
1214
JBG SMITH
JBGS
$1.43B
| $435K | ﹤0.01% |
25,600
| – | – |
|
1215
Nomad Foods
NOMD
$2.12B
| $434K | ﹤0.01% |
25,600
-25,600
| -50% | -$434K |
|
1216
Levi Strauss
LEVI
$8.59B
| $433K | ﹤0.01% |
+26,200
| New | +$433K |
|
1217
Procept Biorobotics
PRCT
$2.09B
| $432K | ﹤0.01% |
10,300
+3,400
| +49% | +$143K |
|
|
SWTX
1218
DELISTED
SpringWorks Therapeutics
SWTX
| $431K | ﹤0.01% |
+11,800
| New | +$431K |
|
1219
Braze
BRZE
$3.35B
| $430K | ﹤0.01% |
8,100
+3,000
| +59% | +$159K |
|
1220
Vericel Corp
VCEL
$1.58B
| $430K | ﹤0.01% |
12,079
-600
| -5% | -$21.4K |
|
|
TGH
1221
DELISTED
Textainer Group Holdings limited
TGH
| $428K | ﹤0.01% |
8,700
-2,100
| -19% | -$103K |
|
1222
Cal-Maine
CALM
$5.31B
| $427K | ﹤0.01% |
7,437
| – | – |
|
|
HCP
1223
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $426K | ﹤0.01% |
+18,000
| New | +$426K |
|
1224
Catalyst Pharmaceutical
CPRX
$2.42B
| $425K | ﹤0.01% |
25,277
-2,600
| -9% | -$43.7K |
|
1225
Extreme Networks
EXTR
$2.96B
| $423K | ﹤0.01% |
24,000
+900
| +4% | +$15.9K |
|